Dengue Academy Masterclass Series 2024 – ISID
AGENDA
The Dengue Academy Masterclass Series consists of four expert-led intensive education courses on dengue science and dengue prevention & control concepts. To foster education and knowledge-sharing about scientific dengue updates, you are cordially invited to join the Dengue Academy Masterclass Series virtually.
16th JANUARY 2024 (Tuesday, 1.00-2.00pm CET)
EMERGING ISSUES IN DENGUE CONTROL
- Somia Iqtadar (Assoc. Professor at King Edward Medical University, Pakistan): Who is affected by dengue? (20 min)
- Xavier Saez Llorens (Head of Infectious Diseases & Director of Clinical Research, Hospital del Niño, Panama): Diagnosis of dengue and viral characterization (20 min)
- Facilitated Q&A (20 min)
18th JANUARY 2024 (Thursday, 1.00-2.00pm CET)
DENGUE IN TRAVELLERS
- Martin Grobusch (Professor of Tropical Medicine at Academic Medical Center, Netherlands): Dengue rates in travellers (20 min)
- Tomas Jelinek (Medical Director at Berlin Centre for Travel and Tropical Medicine, Germany): Unmet medical need of dengue in travellers (20 min)
- Facilitated Q&A (20 min)
30th JANUARY 2024 (Tuesday, 1.00-2.00pm CET)
DENGUE PREVENTION: VACCINATION AS PART OF A COMPREHENSIVE STRATEGY FOR DISEASE CONTROL
- Tikki Pangestu (Visiting Professor at Yong Loo Lin School of Medicine, Singapore): Vaccine hesitancy and confidence (20 min)
- Rosana Richtmann (Head of Infectious Diseases at Grupo Santa Joana, Brazil): Role of vaccination in controlling the spread of dengue (20 min)
- Facilitated Q&A (20 min)
6th FEBRUARY 2024 (Tuesday, 1.00-2.20pm CET)
DENGUE VACCINES
- Lulu Bravo (Professor Emeritus at the College of Medicine, University of the Philippines Manila): Dengue vaccines landscape (20 min)
- Walid Kandeil (Global Dengue Lead, Takeda Vaccine Business Unit, Switzerland): The latest TAK-003 clinical data: scientific discourse (20 min)
- Mayuri Sharma (Director Discovery, Takeda Vaccine Business Unit, USA): Why broad immune characterization is important for a dengue vaccine (20 min)
- Facilitated Q&A (20 min)
Please note: tentative agenda
